Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference97 articles.
1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med.,2005
2. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404;Prados;Int J Radiat Oncol Biol Phys.,2004
3. Adjuvant procarbazine, lomustine and vincristine improves progression free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organization for Research and Treatment of Cancer phase III trial;van den Bent;J Clin Oncol.,2006
4. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials;Wong;J Clin Oncol.,1999
5. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse;Yung;J Clin Oncol.,1999
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map;BMC Cancer;2023-06-14
2. DYRK1A activates NFATC1 to increase glioblastoma migration;Cancer Medicine;2021-07-26
3. M2 macrophage-derived exosomal microRNAs inhibit cell migration and invasion in gliomas through PI3K/AKT/mTOR signaling pathway;Journal of Translational Medicine;2021-03-06
4. Central Nervous System and Peripheral Nerves;The American Cancer Society's Oncology in Practice;2018-02-16
5. Flexible Analogues of Azaindole DYRK1A Inhibitors Elicit Cytotoxicity in Glioblastoma Cells;Australian Journal of Chemistry;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3